$DSS SEC Filings

Filed On	Filing
22 Oct 2026	PRE 14C
20 Oct 2026	Proxy statement: annual meeting on December 2, 2026 say-on-pay vote
24 Sep 2026	Form 4: DSS, Inc., 10% owner · Impact Biomedical Inc Sold 723 shares ($398) · Sold 27 shares ($188) · Sold 156 shares ($1.1K)
21 Sep 2026	8-K: Entry into a Material Definitive Agreement This Securities Purchase Agreement (this “Agreement”) is dated as of September 15, 2026, between DSS, Inc., a New York corporation (the “Company”), and Alset, Inc., a Texas corporation (including its successors and assigns, the “Purchase...
08 Sep 2026	SCHEDULE 13D/A
08 Sep 2026	Form 4: Chan Heng Fai Ambrose, Director Sold 21,852 shares ($17.9K)
04 Sep 2026	424B5
14 Aug 2026	10-Q
09 Jul 2026	Form 4: Chan Heng Fai Ambrose, Director and 2 others Acquired 0 Convertible Promissory Note (Other Transaction) · Acquired 16,554,055 Common Stock Purchase Warrant (Other Transaction) ($15.4M)
09 Jul 2026	SCHEDULE 13D/A
25 Jun 2026	8-K: Entry into a Material Definitive Agreement
09 Jun 2026	RW
15 May 2026	10-Q
14 May 2026	DEF 14C
29 Apr 2026	144
24 Apr 2026	S-1/A
23 Apr 2026	PRE 14C
17 Apr 2026	S-1
10 Apr 2026	DRS
31 Mar 2026	8-K: Entry into a Material Definitive Agreement

Comments